These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1271014)

  • 1. Introduction of B-chain-inactivated ricin into mouse macrophages and rat Kupffer cells via their membrane Fc receptors.
    Refsnes K; Munthe-Kaas AC
    J Exp Med; 1976 Jun; 143(6):1464-74. PubMed ID: 1271014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates of different steps involved in the inhibition of protein synthesis by the toxic lectins abrin and ricin.
    Olsnes S; Sandvig K; Refsnes K; Pihl A
    J Biol Chem; 1976 Jul; 251(13):3985-92. PubMed ID: 932017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgE-immunotoxins. II. IgE-ricin A-chain.
    Boltansky H; Slater J; Youle R; Isersky C; Kaliner M
    Immunopharmacology; 1987 Sep; 14(1):47-62. PubMed ID: 3500150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of Kupffer cells and liver sinusoidal endothelial cells to ricin toxin and ricin toxin-Ab complexes.
    Mooney B; Torres-Velez FJ; Doering J; Ehrbar DJ; Mantis NJ
    J Leukoc Biol; 2019 Nov; 106(5):1161-1176. PubMed ID: 31313388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.
    Youle RJ; Neville DM
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5483-6. PubMed ID: 6968914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation-dependent antigenic determinants in the toxic lectin ricin.
    Olsnes S; Saltvedt E
    J Immunol; 1975 Jun; 114(6):1743-8. PubMed ID: 47877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of binding of the toxic lectins abrin and ricin to surface receptors of human cells.
    Sandvig K; Olsnes S; Pihl A
    J Biol Chem; 1976 Jul; 251(13):3977-84. PubMed ID: 6468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate.
    Raso V; Griffin T
    J Immunol; 1980 Dec; 125(6):2610-6. PubMed ID: 7430640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the accumulation of ricin by hepatic parenchymal and non-parenchymal cells and its inhibition of protein synthesis.
    Skilleter DN; Paine AJ; Stirpe F
    Biochim Biophys Acta; 1981 Nov; 677(3-4):495-500. PubMed ID: 7295807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target ricin by coupling to an anti-macrophage monoclonal antibody.
    Kaminski NE; Roberts JF; Guthrie FE
    J Immunopharmacol; 1986; 8(1):15-37. PubMed ID: 3086461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ricin toxicity to microglial and monocytic cells.
    Battelli MG; Musiani S; Monti B; Buonamici L; Sparapani M; Contestabile A; Stirpe F
    Neurochem Int; 2001 Aug; 39(2):83-93. PubMed ID: 11408086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants.
    Basten A; Miller JF; Abraham R
    J Exp Med; 1975 Mar; 141(3):547-60. PubMed ID: 46915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of cultured primary rat hepatocytes using selection with ricin A subunit.
    Johnston DE; Jasuja R
    Hepatology; 1994 Aug; 20(2):436-44. PubMed ID: 8045505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgE-immunotoxins. I. IgE-intact ricin.
    Boltansky H; Dyer J; Esworthy S; Kaliner M
    Immunopharmacology; 1987 Sep; 14(1):35-45. PubMed ID: 2445711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ricin A chain-containing immunotoxins directed against different epitopes on the delta-chain of cell surface-associated IgD on murine B cells.
    May RD; Finkelman FD; Wheeler HT; Uhr JW; Vitetta ES
    J Immunol; 1990 May; 144(9):3637-42. PubMed ID: 1691764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the endocytosis of immune complexes.
    van Es LA; Daha MR
    Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
    Pietersz GA; Kanellos J; McKenzie IF
    Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface receptors and their dynamics on toxin-treated malignant cells.
    Nicolson GL; Robbins JC; Hyman R
    J Supramol Struct; 1976; 4(1):15-26. PubMed ID: 1256060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.